TRANSGLUTAMINASE 2 (TG2) INHIBITORS
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Slovenian |
Published |
31.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition. |
---|---|
Bibliography: | Application Number: SI20190030559T |